118 related articles for article (PubMed ID: 24451720)
1. Current concepts in brain tumor imaging.
Norden AD; Pope WB; Chang SM
Am Soc Clin Oncol Educ Book; 2012; ():119-24. PubMed ID: 24451720
[TBL] [Abstract][Full Text] [Related]
2. Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.
Jaspan T; Morgan PS; Warmuth-Metz M; Sanchez Aliaga E; Warren D; Calmon R; Grill J; Hargrave D; Garcia J; Zahlmann G
AJNR Am J Neuroradiol; 2016 Sep; 37(9):1581-7. PubMed ID: 27127006
[TBL] [Abstract][Full Text] [Related]
3. RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.
Wen PY; van den Bent M; Youssef G; Cloughesy TF; Ellingson BM; Weller M; Galanis E; Barboriak DP; de Groot J; Gilbert MR; Huang R; Lassman AB; Mehta M; Molinaro AM; Preusser M; Rahman R; Shankar LK; Stupp R; Villanueva-Meyer JE; Wick W; Macdonald DR; Reardon DA; Vogelbaum MA; Chang SM
J Clin Oncol; 2023 Nov; 41(33):5187-5199. PubMed ID: 37774317
[TBL] [Abstract][Full Text] [Related]
4. Response Assessment in Neuro-Oncology Criteria and Clinical Endpoints.
Huang RY; Wen PY
Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):705-718. PubMed ID: 27742111
[TBL] [Abstract][Full Text] [Related]
5. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.
Wen PY; Macdonald DR; Reardon DA; Cloughesy TF; Sorensen AG; Galanis E; Degroot J; Wick W; Gilbert MR; Lassman AB; Tsien C; Mikkelsen T; Wong ET; Chamberlain MC; Stupp R; Lamborn KR; Vogelbaum MA; van den Bent MJ; Chang SM
J Clin Oncol; 2010 Apr; 28(11):1963-72. PubMed ID: 20231676
[TBL] [Abstract][Full Text] [Related]
6. Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas.
Youssef G; Wen PY
Curr Neurol Neurosci Rep; 2024 Feb; 24(2):17-25. PubMed ID: 38170429
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab.
Siegal T; Charbit H; Paldor I; Zelikovitch B; Canello T; Benis A; Wong ML; Morokoff AP; Kaye AH; Lavon I
J Neurosurg; 2016 Oct; 125(4):1008-1015. PubMed ID: 26799295
[TBL] [Abstract][Full Text] [Related]
8. A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults.
Ellingson BM; Sanvito F; Cloughesy TF; Huang RY; Villanueva-Meyer JE; Pope WB; Barboriak DP; Shankar LK; Smits M; Kaufmann TJ; Boxerman JL; Weller M; Galanis E; Groot J; Gilbert MR; Lassman AB; Shiroishi MS; Nabavizadeh A; Mehta M; Stupp R; Wick W; Reardon DA; Vogelbaum MA; van den Bent M; Chang SM; Wen PY
AJNR Am J Neuroradiol; 2024 Jun; ():. PubMed ID: 38926092
[TBL] [Abstract][Full Text] [Related]
9. Response assessment criteria for glioblastoma: practical adaptation and implementation in clinical trials of antiangiogenic therapy.
Chinot OL; Macdonald DR; Abrey LE; Zahlmann G; Kerloëguen Y; Cloughesy TF
Curr Neurol Neurosci Rep; 2013 May; 13(5):347. PubMed ID: 23529375
[TBL] [Abstract][Full Text] [Related]
10. Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma.
Tensaouti F; Khalifa J; Lusque A; Plas B; Lotterie JA; Berry I; Laprie A; Cohen-Jonathan Moyal E; Lubrano V
Neuroradiology; 2017 Oct; 59(10):1013-1020. PubMed ID: 28842741
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Brain Tumor Response: RANO and Its Offspring.
Eisele SC; Wen PY; Lee EQ
Curr Treat Options Oncol; 2016 Jul; 17(7):35. PubMed ID: 27262709
[TBL] [Abstract][Full Text] [Related]
12. Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.
Choi YJ; Kim HS; Jahng GH; Kim SJ; Suh DC
Acta Radiol; 2013 May; 54(4):448-54. PubMed ID: 23592805
[TBL] [Abstract][Full Text] [Related]
13. Disease Assessments in Patients with Glioblastoma.
Phillips KA; Kamson DO; Schiff D
Curr Oncol Rep; 2023 Sep; 25(9):1057-1069. PubMed ID: 37470973
[TBL] [Abstract][Full Text] [Related]
14. Advantages of high b-value diffusion-weighted imaging to diagnose pseudo-responses in patients with recurrent glioma after bevacizumab treatment.
Yamasaki F; Kurisu K; Aoki T; Yamanaka M; Kajiwara Y; Watanabe Y; Takayasu T; Akiyama Y; Sugiyama K
Eur J Radiol; 2012 Oct; 81(10):2805-10. PubMed ID: 22100373
[TBL] [Abstract][Full Text] [Related]
15. Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group.
Vogelbaum MA; Jost S; Aghi MK; Heimberger AB; Sampson JH; Wen PY; Macdonald DR; Van den Bent MJ; Chang SM
Neurosurgery; 2012 Jan; 70(1):234-43; discussion 243-4. PubMed ID: 21593697
[TBL] [Abstract][Full Text] [Related]
16. Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients.
Hutterer M; Hattingen E; Palm C; Proescholdt MA; Hau P
Neuro Oncol; 2015 Jun; 17(6):784-800. PubMed ID: 25543124
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of pseudoprogression in patients with glioblastoma.
Kucharczyk MJ; Parpia S; Whitton A; Greenspoon JN
Neurooncol Pract; 2017 Jun; 4(2):120-134. PubMed ID: 31386017
[TBL] [Abstract][Full Text] [Related]
18. Response Assessment and Magnetic Resonance Imaging Issues for Clinical Trials Involving High-Grade Gliomas.
Boxerman JL; Ellingson BM
Top Magn Reson Imaging; 2015 Jun; 24(3):127-36. PubMed ID: 26049816
[TBL] [Abstract][Full Text] [Related]
19. Advanced MRI Techniques in the Monitoring of Treatment of Gliomas.
Hyare H; Thust S; Rees J
Curr Treat Options Neurol; 2017 Mar; 19(3):11. PubMed ID: 28349351
[TBL] [Abstract][Full Text] [Related]
20. Magnetic Resonance Imaging of Glioma in the Era of Antiangiogenic Therapy.
Khan SN; Linetsky M; Ellingson BM; Pope WB
PET Clin; 2013 Apr; 8(2):163-82. PubMed ID: 27157946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
